In this study, we found that NCAPG2 expression was significantly increased in NSCLC tissues compared to adjacent normal lung tissues, and was closely associated with tumour progression and poor prognosis in lung AD patients. The gene discussed is NCAPG2; the disease is non-small cell lung carcinoma.